cilazapril, anhydrous has been researched along with Diabetic Neuropathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kihara, M; Mitsui, MK; Mitsui, Y; Nakasaka, Y; Okuda, K; Schmelzer, JD; Takahashi, M | 1 |
1 other study(ies) available for cilazapril, anhydrous and Diabetic Neuropathies
| Article | Year |
|---|---|
Altered vasoreactivity to angiotensin II in experimental diabetic neuropathy: role of nitric oxide.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cilazapril; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Logistic Models; Male; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasomotor System | 1999 |